Skip to main content
. 2021 Apr 1;10(7):1415. doi: 10.3390/jcm10071415

Table 3.

Perioperative serum concentration of syndecan-1 and heparan sulfate.

Variable Tranexamic Acid
n = 60
Control
n = 61
p-Value †
Syndecan-1 (ng/mL) p-Value * p-Value *
T0 30.0 (19.6–41.2) 27.3 (19.4–37.1)
T1 28.4 (18.7–38.0) 0.063 28.8 (19.7–36.9) 0.005 0.617
T2 32.6 (20.1–43.0) 0.324 30.7 (22.1–40.9) <0.001 0.907
T0-T1 difference −1.6 (−5.3–2.6) 2.2 (−0.7–4.8) 0.001
T0-T2 difference 0.0 (−3.3–5.5) 3.6 (−0.1–9.3) 0.013
Heparan sulfate (ng/mL)
T0 1.7 (1.0–2.5) 1.6 (0.9–2.9) 0.762
T1 2.2 (1.3–4.2) <0.001 1.9 (1.1–3.4) <0.001 0.544
T2 2.7 (1.8–4.2) <0.001 2.7 (1.5–4.4) <0.001 0.893
T0-T1 difference 0.4 (0.1–1.0) 0.2 (0.0–0.9) 0.272
T0-T2 difference 0.8 (0.3–1.8) 0.9 (0.4–1.7) 0.998

Values are median (interquartile range); * p-value drawn from Wilcoxon signed-rank test to compare the concentrations of the paired serum markers at T1 and T2 from T0; † p-value drawn from Mann–Whitney U tests for comparison between the two groups. T0, preoperative baseline; T1, end of surgery; T2, 2 h post-surgery.